Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCLC, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06067776
What this trial is testing

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Jonathan Riess 36
Testing effectiveness (Phase 2)Study completedNCT00103389
What this trial is testing

Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Cellxpert Biotechnology Corp. 98
Early research (Phase 1)WithdrawnNCT01383668
What this trial is testing

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00003281
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 84
Large-scale testing (Phase 3)Study completedNCT03676192
What this trial is testing

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of Lung
Celltrion 689
Testing effectiveness (Phase 2)Active Not RecruitingNCT03836352
What this trial is testing

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Who this might be right for
Ovarian CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+2 more
ImmunoVaccine Technologies, Inc. (IMV Inc.) 184
Early research (Phase 1)Study completedNCT00052338
What this trial is testing

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02642042
What this trial is testing

Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 60
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Testing effectiveness (Phase 2)Study completedNCT00079235
What this trial is testing

CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664
What this trial is testing

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002656
What this trial is testing

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 20
Not applicableUnknownNCT00693836
What this trial is testing

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Who this might be right for
Lung Cancer
Cancer Research Centre at Weston Park Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT00095199
What this trial is testing

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 939
Not applicableNot Yet RecruitingNCT06848426
What this trial is testing

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

Who this might be right for
Non-Small Cell Lung CancerNon-small Cell Lung Cancer RecurrentNon-small Cell Lung Cancer Stage IIIB+2 more
Jiangxi Provincial People's Hopital 100
Large-scale testing (Phase 3)Study completedNCT00257608
What this trial is testing

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 1,145
Early research (Phase 1)WithdrawnNCT02126527
What this trial is testing

Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT01803269
What this trial is testing

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
University of Chicago 29
Not applicableLooking for participantsNCT02688894
What this trial is testing

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

Who this might be right for
Small Cell Lung CancersNeuroendocrine Carcinoma
Samsung Medical Center 797
Early research (Phase 1)Study completedNCT00132054
What this trial is testing

Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization 30
Next Page